FMR LLC

Position in GTBP — GT Biopharma, Inc.

CIK 315066 BOSTON, MA

Position in GTBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$408

+$138 QoQ

Shares Held

1,000

+1539.3% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

FMR LLC holds $48,167,308,152 across 354 Biotechnology names. GTBP ranks #317 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$408	1,000	+1539.3%	Shares	Defined	2026-05-15
2024-03-31	$270	61	-59.3%	Shares	Defined	2024-05-13
2023-09-30	—	150	-99.3%	Shares	Defined	2023-11-13
2023-06-30	—	23,030	-54.7%	Shares	Defined	2023-08-11
2023-03-31	—	50,882	0.0%	Shares	Defined	2023-08-11
2022-12-31	—	50,882	-1.7%	Shares	Defined	2023-02-13
2022-09-30	—	51,740	-6.3%	Shares	Defined	2022-11-10
2022-06-30	—	55,225	+7.6%	Shares	Defined	2022-08-12
2022-03-31	—	51,345	+40329.1%	Shares	Defined	2022-05-13
2021-09-30	—	127	+370.4%	Shares	Defined	2022-02-14
2021-06-30	—	27	—	Shares	Defined	2021-08-13
No filing history on record for this holder in this stock.